Shenzhou Cell: Revenue of 1.56 billion yuan in 2025, net profit turned from profit to loss.

Shenzhou Cell announced that the total operating income for the year 2025 was 1,560,153,000 yuan, a decrease of 37.91% compared to the previous year; the net profit attributable to the owners of the parent company was -553.29 million yuan, turning from profit to loss. At the end of the reporting period, total assets were 3,833,284,300 yuan, an increase of 16.73% from the beginning of the period; owner's equity attributable to the parent company was 139.56 million yuan, a decrease of 0.95% from the beginning of the period. The main reasons for the performance change were medical insurance cost control, price reduction of core products, increase in commercialization and research and development investment. The data is preliminary and unaudited, subject to the annual report.